The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: A novel mouse model for scleroderma?
Open accessAbstract
OBJECTIVE: Because aberrant Wnt signaling has been linked with systemic sclerosis (SSc) and pulmonary fibrosis, we sought to investigate the effect of Wnt-10b on skin homeostasis and differentiation in transgenic mice and in explanted mesenchymal cells. METHODS: The expression of Wnt-10b in patients with SSc and in a mouse model of fibrosis was investigated. The skin phenotype and biochemical characteristics of Wnt-10b-transgenic mice were evaluated. The in vitro effects of ectopic Wnt-10b were examined in explanted skin fibroblasts and preadipocytes. RESULTS: The expression of Wnt-10b was increased in lesional skin biopsy specimens from patients with SSc and in those obtained from mice with bleomycin-induced fibrosis. Transgenic mice expressing Wnt-10b showed progressive loss of subcutaneous adipose tissue accompanied by dermal fibrosis, increased collagen deposition, fibroblast activation, and myofibroblast accumulation. Wnt activity correlated with collagen gene expression in these biopsy specimens. Explanted skin fibroblasts from transgenic mice demonstrated persistent Wnt/β-catenin signaling and elevated collagen and α-smooth muscle actin gene expression. Wnt-10b infection of normal fibroblasts and preadipocytes resulted in blockade of adipogenesis and transforming growth factor β (TGFβ)-independent up-regulation of fibrotic gene expression. CONCLUSION: SSc is associated with increased Wnt-10b expression in the skin. Ectopic Wnt-10b causes loss of subcutaneous adipose tissue and TGFβ-independent dermal fibrosis in transgenic mice. These findings suggest that Wnt-10b switches differentiation of mesenchymal cells toward myofibroblasts by inducing a fibrogenic transcriptional program while suppressing adipogenesis. Wnt-10b-transgenic mice represent a novel animal model for investigating Wnt signaling in the setting of fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vitro, FIZZ1 suppresses adipogenesis and stimulates myofibroblast differentiation via Notch1 signaling.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [89]
In the citing paper
“Adipocyte to myofibroblast transition is strongly driven by TGFβ (88), Found in inflammatory zone 1 (FIZZ1) and possibly Wnt signaling (89).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis
Brack, A. S., Conboy, M. J., Roy, S., Lee, M., Kuo, C. J., Keller, C., & Rando, T. A. (2007) · Science · doi:10.1126/science.1144090 · Cited by 1,564
Towards an integrated view of Wnt signaling in development
van Amerongen, R., & Nusse, R. (2009) · Development · doi:10.1242/dev.033910 · Cited by 1,213
Systemic sclerosis: a prototypic multisystem fibrotic disorder
Varga, J., & Abraham, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31139 · Cited by 1,187
Self-citationRam�rez-Zacar�as, J. L., Castro‐Muñozledo, F., & Kuri‐Harcuch, W. (1992) · Histochemistry and Cell Biology · doi:10.1007/bf00316069 · Cited by 1,009
Regulation of osteoblastogenesis and bone mass by Wnt10b
Bennett, C. N., Longo, K. A., Hahn, W. S., Suva, L. J., Lane, T. F., Hankenson, K. D., & MacDougald, O. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408742102 · Cited by 898
Self-citationAberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis
Chilosi, M., Poletti, V., Zamò, A., Lestani, M., Montagna, L., Piccoli, P., Pedron, S., Bertaso, M., Scarpa, A., Murer, B., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64282-4 · Cited by 708
Wnt signaling: is the party in the nucleus?Preprint
Willert, K., & Jones, K. A. (2006) · Genes & Development · doi:10.1101/gad.1424006 · Cited by 599
Königshoff, M., Kramer, M., Balsara, N., Wilhelm, J., Amarie, O. V., Jahn, A., Rose, F., Fink, L., Seeger, W., Schaefer, L., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci33950 · Cited by 558
Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis
Königshoff, M., Balsara, N., Pfaff, E.-M., Kramer, M., Chrobak, I., Seeger, W., & Eickelberg, O. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002142 · Cited by 511
Cited by
Sorted by citations
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
Akhmetshina, A., Palumbo, K., Dees, C., Bergmann, C., Venalis, P., Zerr, P., Horn, A., Kireva, T., Beyer, C., Zwerina, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1734 · Cited by 843
Self-citationShared and distinct mechanisms of fibrosis
Distler, J. H. W., Györfi, A., Ramanujam, M., Whitfield, M. L., Königshoff, M., & Lafyatis, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0322-7 · Cited by 674
Self-citationHinz, B. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2015.07.009 · Cited by 424
Mesenchymal stem cells in fibrotic disease
El Agha, E., Kramann, R., Schneider, R. K., Li, X., Seeger, W., Humphreys, B. D., & Bellusci, S. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.07.011 · Cited by 430
Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
Bhattacharyya, S., Wei, J., & Varga, J. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.149 · Cited by 381
Self-citationMarangoni, R. G., Korman, B. D., Wei, J., Wood, T. A., Graham, L. V., Whitfield, M. L., Scherer, P. E., Tourtellotte, W. G., & Varga, J. (2015) · Arthritis & Rheumatology · doi:10.1002/art.38990 · Cited by 337
Self-citationThe role of myofibroblasts in wound healing
Hinz, B. (2016) · Current Research in Translational Medicine · doi:10.1016/j.retram.2016.09.003 · Cited by 328
Varga, J., Trojanowska, M., & Kuwana, M. (2017) · Journal of Scleroderma and Related Disorders · doi:10.5301/jsrd.5000249 · Cited by 327
Self-citationFibrosis—a lethal component of systemic sclerosis
Ho, Y. Y., Lagares, D., Tager, A. M., & Kapoor, M. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.53 · Cited by 316
Targeting TGF-β signaling for the treatment of fibrosis
Györfi, A., Matei, A., & Distler, J. H. W. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.12.016 · Cited by 283
Myofibroblast transcriptome indicates SFRP2hi fibroblast progenitors in systemic sclerosis skin
Tabib, T., Huang, M., Morse, N., Papazoglou, A., Behera, R., Jia, M., Bulik, M., Monier, D., Benos, P. V., Chen, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24607-6 · Cited by 273
Self-citationWnt/β-Catenin Signaling: a Promising New Target for Fibrosis Diseases
GUO, Y., XIAO, L., Sun, L., & Liu, F. (2012) · Physiological Research · doi:10.33549/physiolres.932289 · Cited by 252
Wei, J., Fang, F., Lam, A. P., Sargent, J. L., Hamburg, E., Hinchcliff, M. E., Gottardi, C. J., Atit, R., Whitfield, M. L., & Varga, J. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34424 · Cited by 226
Self-citationThe tension biology of wound healing
Harn, H. I., Ogawa, R., Hsu, C., Hughes, M. W., Tang, M., & Chuong, C. (2017) · Experimental Dermatology · doi:10.1111/exd.13460 · Cited by 213
β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis
Beyer, C., Schramm, A., Akhmetshina, A., Dees, C., Kireva, T., Gelse, K., Sonnylal, S., de Crombrugghe, B., Taketo, M. M., Distler, O., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200568 · Cited by 203
Dees, C., Schlottmann, I., Funke, R., Distler, A., Palumbo‐Zerr, K., Zerr, P., Lin, N., Beyer, C., Distler, O., Schett, G. A., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203194 · Cited by 209
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
Gilbane, A. J., Denton, C. P., & Holmes, A. M. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4230 · Cited by 196
β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target
Lam, A. P., & Gottardi, C. J. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32834b3309 · Cited by 191
Self-citationMechanotransduction in Wound Healing and Fibrosis
Kuehlmann, B. A., Bonham, C. A., Zucal, I., Prantl, L., & Gurtner, G. C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051423 · Cited by 182
Strategies for anti-fibrotic therapies
Rosenbloom, J., Mendoza, F. A., & Jiménez, S. A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.007 · Cited by 174
Latella, G., Rogler, G., Bamias, G., Breynaert, C. M., Florholmen, J., Pellino, G., Reif, S. S., Speca, S., & Lawrance, I. C. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.03.008 · Cited by 169
Altorok, N., Tsou, P., Coit, P., Khanna, D., & Sawalha, A. H. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205303 · Cited by 162
Human Fibrotic Diseases: Current Challenges in Fibrosis Research
Rosenbloom, J., Macarak, E. J., Piera-Velázquez, S., & Jiménez, S. A. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7113-8_1 · Cited by 160
Unraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
Dawson, K., Aflaki, M., & Nattel, S. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.235382 · Cited by 150
Bastakoty, D., & Young, P. P. (2016) · The FASEB Journal · doi:10.1096/fj.201600502r · Cited by 139
Aprelikova, O. N., Palla, J. B., Hibler, B. P., Yu, X., Greer, Y. E., Yi, M., Stephens, R., Maxwell, G. L., Jazaeri, A. A., Risinger, J. I., et al. (2012) · Oncogene · doi:10.1038/onc.2012.351 · Cited by 122
Fu, J., & Hsu, W. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.407 · Cited by 119
Emerging Role and Therapeutic Implication of Wnt Signaling Pathways in Autoimmune Diseases
Shi, J., Chi, S., Xue, J., Yang, J., Li, F., & Liu, X. (2016) · Journal of Immunology Research · doi:10.1155/2016/9392132 · Cited by 122
Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis
Beyer, C., Reichert, H., Akan, H., Mallano, T., Schramm, A., Dees, C., Palumbo‐Zerr, K., Lin, N., Distler, A., Gelse, K., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202544 · Cited by 117
Self-citationCellular and molecular mechanisms in fibrosis
Dees, C., Chakraborty, D., & Distler, J. H. W. (2020) · Experimental Dermatology · doi:10.1111/exd.14193 · Cited by 115
Cancer-Associated Adipocytes in Breast Cancer: Causes and Consequences
Rybińska, I., Mangano, N., Tagliabue, E., & Triulzi, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073775 · Cited by 108
Interstitial Lung Disease in Scleroderma
Schoenfeld, S. R., & Castelino, F. V. (2015) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2014.12.005 · Cited by 99
The role of WNT10B in physiology and disease
Wend, P., Wend, K., Krum, S. A., & Miranda‐Carboni, G. A. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02296.x · Cited by 97
González, E. G., Selvi, E., Balistreri, E., Akhmetshina, A., Palumbo, K., Lorenzini, S., Lazzerini, P. E., Montilli, C., Capecchi, P. L., Lucattelli, M., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200314 · Cited by 95
Skin fibrosis: Models and mechanisms
Do, N., & Eming, S. A. (2016) · Current Research in Translational Medicine · doi:10.1016/j.retram.2016.06.003 · Cited by 98
Pathogenesis of systemic sclerosis—current concept and emerging treatments
Furue, M., Mitoma, C., Mitoma, H., Tsuji, G., Chiba, T., Nakahara, T., Uchi, H., & Kadono, T. (2017) · Immunologic Research · doi:10.1007/s12026-017-8926-y · Cited by 94
Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis
Korman, B. D. (2019) · Translational research · doi:10.1016/j.trsl.2019.02.010 · Cited by 91
Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling
Distler, A., Deloch, L., Huang, J., Dees, C., Lin, N., Palumbo‐Zerr, K., Beyer, C., Weidemann, A., Distler, O., Schett, G. A., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202275 · Cited by 91
A Glimpse of the Pathogenetic Mechanisms of Wnt/ β -Catenin Signaling in Diabetic Nephropathy
Xiao, L., Wang, M., Yang, S., Liu, F., & Sun, L. (2013) · BioMed Research International · doi:10.1155/2013/987064 · Cited by 83
Long noncoding RNA H19X is a key mediator of TGF-β–driven fibrosis
Pachera, E., Assassi, S., Salazar, G. A., Stellato, M., Renoux, F., Wunderlin, A. S., Błyszczuk, P., Lafyatis, R., Kurreeman, F. A. S., de Vries-Bouwstra, J. K., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135439 · Cited by 83
Self-citationGrünberg, J. R., Hammarstedt, A., Hedjazifar, S., & Smith, U. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.511964 · Cited by 78
Perumal, M. K., Perumal, N., Samidurai, M., Devaraj, H., & NiranjaliDevaraj, S. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.03.008 · Cited by 79
Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis
Wang, J., Li, L., Li, L., Qi, Y., Li, J., & Xu, T. (2018) · Gene · doi:10.1016/j.gene.2018.06.053 · Cited by 80
Heazell, A. E. P., Hayes, D. J. L., Whitworth, M. K., Takwoingi, Y., Bayliss, S. E., & Davenport, C. F. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012245.pub2 · Cited by 83
Integrins and cadherins as therapeutic targets in fibrosis
Agarwal, S. K. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00131 · Cited by 75
Modulating hair follicle size with W nt10b/ DKK 1 during hair regeneration
Lei, M., Guo, H., Qiu, W., Lai, X., Yang, T., Widelitz, R. B., Chuong, C., Lian, X., & Yang, L. (2014) · Experimental Dermatology · doi:10.1111/exd.12416 · Cited by 72
Mechanical and Immunological Regulation in Wound Healing and Skin Reconstruction
Kimura, S., & Tsuji, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115474 · Cited by 69
Wu, M., Pedroza, M., Lafyatis, R., George, A., Mayes, M. D., Assassi, S., Tan, F. K., Brenner, M. B., & Agarwal, S. K. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38275 · Cited by 68
Self-citationCanonical Wnt signalling as a key regulator of fibrogenesis – implications for targeted therapies?
Dees, C., & Distler, J. H. W. (2013) · Experimental Dermatology · doi:10.1111/exd.12255 · Cited by 69
Autocrine lysophosphatidic acid signaling activates β-catenin and promotes lung allograft fibrosis
Cao, P., Aoki, Y., Badri, L., Walker, N., Manning, C. M., Lagstein, A., Fearon, E. R., & Lama, V. N. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88896 · Cited by 66
Dermal white adipose tissue implicated in SSc pathogenesis
Varga, J., & Marangoni, R. G. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.223 · Cited by 64
Self-citationAnimal models of scleroderma: recent progress
Marangoni, R. G., Varga, J., & Tourtellotte, W. G. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000331 · Cited by 61
Self-citationTrinh‐Minh, T., Chen, C.-W., Manh, C. T., Li, Y., Zhu, H., Zhou, X., Chakraborty, D., Zhang, Y., Rauber, S., Dees, C., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci159884 · Cited by 71
Reich, N., Tomčík, M., Zerr, P., Lang, V. R., Dees, C., Avouac, J., Palumbo, K., Horn, A., Akhmetshina, A., Beyer, C., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200412 · Cited by 63
The Dishevelled-binding protein CXXC5 negatively regulates cutaneous wound healing
Lee, S.-H., Kim, M., Kim, H.-Y., Lee, Y. M., Kim, H., Nam, K. A., Roh, M. R., Min, D. S., Chung, K. Y., & Choi, K. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20141601 · Cited by 60
Genetic alterations and epigenetic alterations of cancer-associated fibroblasts
Du, H., & Che, G. (2016) · Oncology Letters · doi:10.3892/ol.2016.5451 · Cited by 63
Recent Advances in Understanding the Pathogenesis of Scleroderma-Interstitial Lung Disease
Akter, T., Silver, R. M., & Bogatkevich, G. S. (2014) · Current Rheumatology Reports · doi:10.1007/s11926-014-0411-1 · Cited by 57
Jin, J., Ou, Q., Wang, Z., Tian, H., Xu, J., Gao, F., Hu, S., Chen, J., Wang, J., Zhang, J., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02400-y · Cited by 57
Wei, J., Bhattacharyya, S., Jain, M., & Varga, J. (2012) · The Open Rheumatology Journal · doi:10.2174/1874312901206010103 · Cited by 58
Self-citationThe molecular pathogenesis of morphoea: from genetics to future treatment targets
Saracino, A., Denton, C. P., & Orteu, C. H. (2016) · British Journal of Dermatology · doi:10.1111/bjd.15001 · Cited by 58
Li, J., Dai, Y., Zhu, H., Jiang, Y., & Zhang, S. (2016) · Human Reproduction · doi:10.1093/humrep/dew058 · Cited by 55
Lafyatis, R., Mantero, J. C., Gordon, J., Kishore, N., Carns, M., Dittrich, H., Spiera, R., Simms, R. W., & Varga, J. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.06.032 · Cited by 59
Self-citationTargeting the Wnt Signaling Pathway in Liver Fibrosis for Drug Options: An Update
Duspara, K., Bojanic, K., Pejic, J. I., Kuna, L., Kolarić, T. O., Nincevic, V., Smolić, R., Vcev, A., Glasnovic, M., Curcic, I. B., et al. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00065 · Cited by 60
Inhibition of Wnt/β‐catenin pathway promotes regenerative repair of cutaneous and cartilage injury
Bastakoty, D., Saraswati, S., Cates, J., Lee, E. N., Nanney, L. B., & Young, P. P. (2015) · The FASEB Journal · doi:10.1096/fj.15-275941 · Cited by 54
Systemic effects of Wnt signaling
Maruotti, N., Corrado, A., Neve, A., & Cantatore, F. P. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24326 · Cited by 52
Dendritic cells maintain dermal adipose–derived stromal cells in skin fibrosis
Chia, D. J., Zhu, T., Chyou, S., Dasoveanu, D., Carballo, C. B., Tian, S., MAGRO, C. M. J., Rodeo, S. A., Spiera, R., Ruddle, N. H., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85740 · Cited by 52
Self-citationContreras, O., Soliman, H. S., Théret, M., Rossi, F. M. V., & Brandan, E. (2020) · Journal of Cell Science · doi:10.1242/jcs.242297 · Cited by 52
Gillespie, J., Ross, R. L., Corinaldesi, C., Esteves, F., Derrett‐Smith, E. C., McDermott, M., Doody, G. M., Denton, C. P., Emery, P., & Galdo, F. D. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40437 · Cited by 50
Origin of fibrosing cells in systemic sclerosis
Ebmeier, S., & Horsley, V. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000217 · Cited by 48
The role of WNT10B in physiology and disease: A 10-year update
Perkins, R. S., Singh, R., Abell, A. N., Krum, S. A., & Miranda‐Carboni, G. A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1120365 · Cited by 49
Sustained β-Catenin Activity in Dermal Fibroblasts Is Sufficient for Skin Fibrosis
Hamburg‐Shields, E., & Atit, R. P. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.155 · Cited by 45
Taiyab, A., Korol, A. S., Deschamps, P. A., & West‐Mays, J. A. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20162 · Cited by 46
Fibrosis in systemic sclerosis: common and unique pathobiology
Bhattacharyya, S., Wei, J., Tourtellotte, W. G., Hinchcliff, M., Gottardi, C. J., & Varga, J. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s18 · Cited by 45
Self-citationPoly(ADP-ribose) polymerase-1 regulates fibroblast activation in systemic sclerosis
Zhang, Y., Pötter, S., Chen, C., Liang, R., Gelse, K., Ludolph, I., Horch, R. E., Distler, O., Schett, G. A., Distler, J. H. W., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212265 · Cited by 43
White Adipocyte Plasticity in Physiology and Disease
Bielczyk-Maczyńska, E. (2019) · Cells · doi:10.3390/cells8121507 · Cited by 44
Epigenetic Factors as Drivers of Fibrosis in Systemic Sclerosis
Bergmann, C., & Distler, J. H. W. (2017) · Epigenomics · doi:10.2217/epi-2016-0150 · Cited by 43
Lin, X., Zha, Y., Zeng, X.-Z., Dong, R., Wang, Q.-H., & Wang, D. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6461 · Cited by 41
Liu, J., Zhao, B., Zhu, H., Pan, Q., Cai, M., Bai, X., Li, X., Hu, X., Zhang, M., Shi, J., et al. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03110-x · Cited by 41
Shaikh, G., Zhang, J., Pérez‐Aso, M., Mediero, A., & Cronstein, B. N. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13615 · Cited by 41
Rosa, I., Romano, E., Fioretto, B. S., Matucci‐Cerinic, M., & Manetti, M. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i1.30 · Cited by 40
Role of Mesenchymal Stem Cells and Extracellular Vesicles in Idiopathic Pulmonary Fibrosis
Kletukhina, S. K., Mutallapova, G., Андреевна, Т. А., & Gomzikova, M. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911212 · Cited by 38
Li, X., Liu, Y., Tang, Y., & Xia, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1474688 · Cited by 46
Taki, Z., Gostjeva, E. V., Thilly, W. G., Yaseen, B., Lopez, H., Mirza, M., Hassuji, Z., Vigneswaran, S., Abdi, B. A., Hart, A., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41267 · Cited by 39
Recent Advances in the Genetics of Systemic Sclerosis: Toward Biological and Clinical Significance
Korman, B. D., & Criswell, L. A. (2015) · Current Rheumatology Reports · doi:10.1007/s11926-014-0484-x · Cited by 36
The Ubiquitin Proteasome System and Skin Fibrosis
Shen, W., Zhang, Z., Ma, J., Lü, D., & Lyu, L. (2021) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00509-z · Cited by 37
Second pregnancy outcomes for women with systemic lupus erythematosus
Shand, A., Algert, C. S., MARCH, L. M., & Roberts, C. L. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201210 · Cited by 37
Distler, A., Lang, V. R., Vecchio, T. D., Huang, J., Zhang, Y., Beyer, C., Lin, N., Palumbo‐Zerr, K., Distler, O., Schett, G. A., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204221 · Cited by 38
Epigenetics and systemic sclerosis
Altorok, N., & Kahaleh, B. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0504-6 · Cited by 35
Taylan, A., Bırlık, M., Kenar, G., Toprak, B., Gündoğdu, B., Gürler, O., Karakaş, B., Akıncı, B., & Şişman, A. R. (2018) · Modern Rheumatology · doi:10.1080/14397595.2018.1500736 · Cited by 35
Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis
Beyer, C., Dees, C., & Distler, J. H. W. (2012) · Archives of Dermatological Research · doi:10.1007/s00403-012-1304-7 · Cited by 35
Chen, C., Beyer, C., Liu, J., Maier, C., Li, C., Trinh‐Minh, T., Xu, X., Cole, S. H., Hsieh, M. H., Ng, N., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210294 · Cited by 33
Jeon, K., Phipps, R. P., Sime, P. J., & Huxlin, K. R. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.04.002 · Cited by 33
Fibrotic Response to Biomaterials and all Associated Sequence of Fibrosis
Jones, K. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800196-7.00009-8 · Cited by 33
MicroRNAs Regulating Signaling Pathways: Potential Biomarkers in Systemic Sclerosis
Li, Y., Huang, J., Guo, M., & Zuo, X. (2015) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2015.07.001 · Cited by 32
Are hair follicle stem cells promising candidates for wound healing?
Li, B., Hu, W., Ma, K., Zhang, C., & Fu, X. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1559290 · Cited by 31
Morphogen Pathways in Systemic Sclerosis
Beyer, C., & Distler, J. H. W. (2012) · Current Rheumatology Reports · doi:10.1007/s11926-012-0299-6 · Cited by 31
Dkk1: A key molecule in joint remodelling and fibrosis
Klavdianou, K., Liossis, S. C., & Daoussis, D. (2017) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.28.4.174 · Cited by 31
Wang, J., Cai, J., Zhang, Q., Wen, J., Liao, Y., & Lu, F. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03127-0 · Cited by 29
Metadata
- Authors
- Wei, J., Melichian, D., Komura, K., Hinchcliff, M., Lam, A. P., Lafyatis, R., Gottardi, C. J., MacDougald, O. A., & Varga, J.
- Affiliations
- Northwestern University (US)
- Boston University (US)
- University of Michigan (US)
- ORCID
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2011-05-31
- Volume
- 63
- Issue
- 6
- Pages
- 1707-1717
- ISSN
- 0004-3591 (ISSN-L)
- PMC
- PMC3124699
- OpenAlex
- W1967131493
- Cited by
- 214
- References
- 52
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 12 · 2023: 6 · 2022: 8 · 2021: 18 · 2020: 12 · 2019: 14 · 2018: 13 · 2017: 22 · 2016: 23 · 2015: 18 · 2014: 13 · 2013: 16 · 2012: 23
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Arthritis & Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P30HL101292, R01HL094643, K08HL093216)
- National Institute of Diabetes and Digestive and Kidney Diseases (R56DK062876, DK-51563, N02 DK062876, R01DK051563, R01DK062876)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR49025, R01AR051089, R01AR049025)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Keywords
- Wnt signaling, systemic sclerosis, skin fibrosis, myofibroblast differentiation, adipogenesis, collagen deposition, Wnt/β-catenin signaling, bleomycin-induced fibrosis, transgenic mouse model, dermal fibroblasts, preadipocytes
- MeSH terms
- Actins, Animals, Bleomycin, Collagen, Disease Models, Animal, Female, Fibroblasts, Fibrosis, Humans, Lipodystrophy, Mice, Transgenic, Scleroderma, Systemic, Skin, Gene Expression, Cell Culture Techniques, Adipogenesis, Wnt Proteins, beta Catenin, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
